| Tanespimycin |
ENSG00000088970.11 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000104691.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000117242.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000117242.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000124915.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000126005.11 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000131484.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000135253.9 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000135253.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000149656.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000157306.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000163597.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000164621.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000167912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000167912.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000168367.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000170161.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000172250.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000173867.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000174365.15 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000175061.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000175147.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000175611.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000175611.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000175772.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000177337.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000177337.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000177337.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000177640.11 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000177640.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000177738.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000177757.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000177757.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000177853.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000177993.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000178248.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000178440.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000179743.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000179743.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000179859.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000179935.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000180139.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000180279.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000180458.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000180846.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000180846.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000181097.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000181798.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000182109.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000182376.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000182873.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000184068.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000184068.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000185044.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000185186.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000185847.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000186019.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000186594.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000188424.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000188424.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000189223.9 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000189223.9 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000189295.9 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000196421.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000196421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000196553.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000196553.9 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000196668.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000196696.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000196810.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000196810.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000196951.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000197308.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000197308.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000197670.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000197670.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000198221.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000198221.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000198468.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000198547.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000203258.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000203279.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000203280.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000203280.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000203288.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000203362.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000203386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000203441.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000203496.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000203497.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000203497.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000203499.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000203506.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000203506.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000203645.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000203706.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000203739.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000203801.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000203865.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000203865.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000203999.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000203999.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000203999.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000204091.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000204091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000204362.5 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000204588.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000204758.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000204791.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000204802.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000204802.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000204815.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000204837.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000204837.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000204837.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000204860.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000205041.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000205041.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000205444.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000205500.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000205559.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000205562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000205632.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000205837.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000205885.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000205913.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000205913.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000206028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000206028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000206129.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000206140.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000206142.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000206337.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000206337.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000206417.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000206417.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000206573.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000211683.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000211683.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000212663.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000212694.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000212939.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000213468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000213863.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000213971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000213971.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000213971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000214145.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000214184.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000214347.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000214546.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000214548.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000214650.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000214719.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000214770.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000214772.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000214870.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000214922.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000215068.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000215068.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000215246.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000215256.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000215394.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000215417.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000215417.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000215417.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000215447.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000215458.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000215458.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000215498.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000215533.4 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000215769.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000215863.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000215866.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000217576.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000218018.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000218018.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000220161.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000223356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223380.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000223401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000223442.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000223477.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000223478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000223478.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000223486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223552.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000223561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223576.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000223579.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223579.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223642.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223643.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223652.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000223685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223692.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223745.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000223749.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000223754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223779.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000223806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223831.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223839.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000223884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000223930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000223949.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000223979.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000223979.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000224000.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000224020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224020.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000224031.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000224032.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224043.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000224050.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224078.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224079.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000224090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224189.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000224356.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224376.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000224384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224429.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224460.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000224481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224505.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224511.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224541.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224577.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000224596.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000224616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224729.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224729.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224790.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000224799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224805.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000224810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224843.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000224883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000224888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224888.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224905.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000224914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000224939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000224969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000224992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225057.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000225087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225092.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000225096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225096.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000225111.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000225113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225156.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225163.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000225163.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000225177.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000225194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225195.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000225205.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000225210.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225269.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225278.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000225280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225292.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000225353.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000225407.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000225407.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000225411.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225489.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000225518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225532.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000225579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225595.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000225602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000225620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225684.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000225733.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000225745.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000225746.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225751.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000225760.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000225762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000225778.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000225783.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225783.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225850.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225930.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000225931.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000225969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000225973.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000225975.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000225975.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226091.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000226200.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226200.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000226238.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226287.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000226287.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000226332.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000226352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226352.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000226352.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226363.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226363.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000226363.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000226381.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226386.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000226386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000226386.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000226445.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000226471.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000226505.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000226508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226516.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226562.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226578.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000226581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226604.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226637.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000226648.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226711.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000226746.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226758.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000226803.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000226819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226822.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000226824.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000226833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226852.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226853.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226853.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000226853.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000226864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000226869.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000226869.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226869.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000226889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226900.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000226944.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227036.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000227060.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227070.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000227082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000227098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227107.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000227117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227155.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227192.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000227220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227256.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000227285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227354.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000227374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227388.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227388.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000227388.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227388.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000227398.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000227409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227431.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227492.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227502.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000227512.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000227527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227527.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227543.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000227591.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000227603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227617.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000227627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000227680.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227726.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000227773.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000227885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227885.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000227888.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000227896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000227896.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227908.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000227953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000227959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000228016.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228031.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000228037.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000228060.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000228065.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228106.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000228113.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228140.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000228150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000228192.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000228203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228204.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228214.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000228222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228294.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228302.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228315.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000228353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000228358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228372.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000228386.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228389.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000228397.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228397.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000228414.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228437.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000228444.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000228485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228506.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000228509.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000228526.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000228540.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228624.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228649.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000228714.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000228719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228723.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000228742.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228775.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228775.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000228775.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000228784.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228794.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228839.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000228889.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000228889.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000228917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229017.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000229056.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229105.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000229118.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000229122.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229124.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229137.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000229152.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000229152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229167.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000229167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000229195.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000229214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229228.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229267.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000229444.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229525.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000229531.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000229539.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229582.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000229645.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000229647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000229692.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000229697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229702.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000229727.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229766.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229832.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000229839.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000229848.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000229867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229915.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000229931.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000229950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000229952.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000229953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229970.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229980.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229980.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000229999.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000230005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000230013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230013.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000230021.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000230090.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230124.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000230126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000230155.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230257.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000230289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230368.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000230424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230424.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000230432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230439.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230454.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230454.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000230461.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230513.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000230526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230555.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230555.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230565.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000230606.6 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000230613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000230732.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230735.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230773.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000230790.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000230834.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000230836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230844.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230844.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000230850.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230880.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230899.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000230912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000230914.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000230914.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000230922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230925.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000230925.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000230928.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000230945.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230960.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000230968.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231028.4 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000231050.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231050.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000231057.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231079.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231104.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231119.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231160.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231172.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000231188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231201.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231312.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000231327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231393.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000231401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231422.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231422.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000231429.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000231435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231441.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231460.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231460.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231473.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231473.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000231481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231485.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231528.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000231530.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231551.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231551.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231566.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231595.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000231607.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231609.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231611.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231612.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231628.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000231636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000231651.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000231652.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231652.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231703.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231704.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000231711.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000231728.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231731.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231734.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231764.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231764.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000231769.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231769.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231856.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231858.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231889.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000231903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231948.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000231980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000231993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000231999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232018.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232021.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232023.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232046.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232104.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232151.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232274.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232284.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232316.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000232324.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000232336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232352.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232363.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000232377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232386.5 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000232406.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232406.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000232411.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000232445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232453.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000232461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232470.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000232500.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232519.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232527.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000232536.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232564.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000232586.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000232593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232645.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232648.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000232648.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232677.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232686.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232693.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000232710.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232710.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232729.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232732.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000232762.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000232811.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232860.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000232876.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232907.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232907.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232931.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000232936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232978.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000232995.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000232995.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000233008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000233038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233064.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233064.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000233077.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000233080.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233110.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233117.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000233117.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000233137.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000233143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233184.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233220.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000233221.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000233223.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000233230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233251.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233334.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233355.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000233363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233396.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233429.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000233430.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233527.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000233547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233547.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000233554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233554.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000233593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000233613.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000233613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233635.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233651.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233654.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000233654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000233705.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233757.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000233775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233775.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233783.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000233806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233817.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233852.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000233862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233885.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233885.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000233893.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000233895.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000233901.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000233926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000233930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000233975.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234134.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234155.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000234160.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000234183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234215.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234225.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234225.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000234232.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234264.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000234281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000234286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234327.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234394.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234423.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234432.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000234492.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234616.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234616.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234650.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000234663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234684.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000234690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234741.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234741.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000234771.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234771.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234773.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234773.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234793.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000234807.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000234817.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234817.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000234848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234902.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000234928.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000234936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234943.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234996.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000234996.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235051.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000235072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235072.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000235078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000235092.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235092.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000235100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235117.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000235117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235172.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000235209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235214.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235214.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000235215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235244.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235257.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235314.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235381.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235398.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235423.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235426.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000235448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000235453.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235475.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235481.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235529.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000235560.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235560.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235590.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000235609.4 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000235641.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235659.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235706.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235706.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000235724.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000235724.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000235741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000235770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000235781.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000235786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000235823.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000235843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235848.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235872.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000235897.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000235904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235910.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235927.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000235954.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236031.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000236094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236107.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236204.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000236209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000236266.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000236299.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000236305.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236308.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000236383.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000236404.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000236426.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000236438.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000236451.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000236464.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236502.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236535.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000236558.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236591.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000236591.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000236611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236617.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000236671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236719.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236780.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236780.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000236790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236830.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000236842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000236859.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236889.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000236896.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000236901.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000236935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000236943.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236947.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000236947.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000236991.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237015.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000237015.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000237017.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000237021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237021.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000237036.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000237037.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237037.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237125.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237248.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237253.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000237280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000237281.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000237291.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237298.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000237310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000237331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237356.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000237357.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000237402.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000237404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237404.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000237407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237424.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000237429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237436.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000237489.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237499.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000237499.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237520.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237531.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237588.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237594.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237689.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237718.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237738.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000237750.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237753.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000237756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237781.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237803.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237807.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237877.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237903.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000237903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237940.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237940.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000237943.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237975.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000237975.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000237978.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000238009.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000238039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238039.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000238039.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000238113.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000238123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000238123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238140.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000238140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000238141.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238164.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238164.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000238186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000238197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238261.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238261.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238266.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000238273.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000238273.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000238290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000239213.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000239219.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000239300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000239335.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000239377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000239462.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000239462.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000239523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000239533.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000239569.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000239608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000239608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000239828.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000239906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000239911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000240005.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000240086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000240093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000240143.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000240175.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000240291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000240350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000240440.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000240476.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000240498.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000240549.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000240567.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000240571.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000240591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000240758.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000240766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000240766.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000240770.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000240790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000240790.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000240790.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000240859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000240859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000240907.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000240990.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000240996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000241211.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000241219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000241288.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000241313.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000241359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000241481.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000241525.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000241560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000241684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000241764.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000241886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000241933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000241933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000241985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000242094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000242125.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000242147.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000242258.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000242357.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000242391.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000242553.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000242569.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000242628.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000242686.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000242687.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000242759.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000242767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000242798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000243018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000243055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000243069.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000243107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000243176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000243220.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000243230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000243230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000243243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000243319.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000243319.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000243350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000243368.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000243389.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000243389.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000243479.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000243479.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000243533.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000243629.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000243637.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000243701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000243795.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000243819.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000243836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000243944.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000243960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000243960.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000243960.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000244040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000244124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244124.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000244128.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000244161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000244260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244300.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244300.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000244306.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244380.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244393.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000244479.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000244558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244649.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000244649.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000244676.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000244998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245080.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000245164.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000245281.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245293.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245322.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245322.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000245322.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000245466.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000245532.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000245552.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245552.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000245648.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000245651.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000245667.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245694.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000245711.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000245812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245849.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000245857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245904.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245954.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000245975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000245975.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000245975.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000246067.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000246130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246174.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000246174.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000246225.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246228.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000246228.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000246263.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000246323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000246339.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246339.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246379.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000246465.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246548.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246582.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246627.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246627.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246640.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000246640.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000246640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000246695.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000246731.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246731.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000246731.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000246777.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000246790.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000246792.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000246877.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000246898.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000246898.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000246982.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000246985.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000246985.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000247151.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000247199.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000247199.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000247213.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000247228.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000247324.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000247400.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000247416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000247572.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000247675.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000247675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000247679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000247708.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000247775.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000247796.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000247828.3 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000247950.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000247982.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000248092.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248240.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000248243.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000248265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248323.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000248323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000248399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248429.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000248445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000248544.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000248559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000248664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000248668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248671.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000248693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000248698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248734.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000248774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000248858.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000248866.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000248866.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000248964.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000248964.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000248968.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000249054.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249116.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000249167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000249196.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000249199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249241.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249307.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000249307.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000249309.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249346.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249348.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000249348.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000249356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249487.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249487.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249494.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249500.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249592.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000249595.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000249604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249650.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249673.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249684.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000249685.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000249685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249690.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249700.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000249713.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249786.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249846.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000249894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000249899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000249923.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000249996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250012.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000250049.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000250069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000250072.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000250101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250101.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000250107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000250129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250129.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000250167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250220.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000250222.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250222.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000250260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250267.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000250280.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000250286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000250302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250312.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000250343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000250365.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250365.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000250365.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250397.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000250404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250410.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000250415.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250447.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000250448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250508.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000250541.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000250551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250604.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250608.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000250616.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000250629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250659.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250714.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250714.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250734.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000250740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000250742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000250765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250770.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000250786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250802.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000250838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250903.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000250903.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000250909.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000250910.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250948.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000250957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000250986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251003.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251072.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251072.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000251141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000251161.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251175.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000251175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000251179.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251191.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000251194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251279.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000251301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251323.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000251359.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000251379.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000251396.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000251442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251461.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000251555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000251556.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000251602.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000251611.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000251615.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000251666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000253121.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000253161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000253168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000253174.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253174.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253197.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000253210.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253227.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253227.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253301.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000253307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253315.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000253317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253327.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253369.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000253374.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000253390.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000253399.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000253433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253522.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000253535.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253559.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253567.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000253572.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000253576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253632.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253636.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253653.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000253669.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000253696.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000253704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253704.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253706.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000253712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000253754.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000253784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253829.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000253837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000253854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253893.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000253930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253955.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000253965.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000253983.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000253986.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000254027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000254042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254154.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254162.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000254192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000254208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254208.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254275.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000254343.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000254363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254414.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000254414.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000254419.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000254419.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000254427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254468.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000254477.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000254480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000254485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254495.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254592.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000254602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000254602.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000254610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254671.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000254682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000254687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254842.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254860.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000254864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254934.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000254964.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000254964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000254966.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000254981.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255008.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255026.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255045.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000255052.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255121.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255121.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255135.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255135.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000255159.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000255160.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255164.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255165.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255182.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255197.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000255202.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000255234.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000255236.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000255241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000255248.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255276.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000255299.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000255306.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255364.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255409.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000255410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000255503.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255517.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000255545.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255621.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000255651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255741.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255856.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000255867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000255966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000255966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000255966.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000255983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256050.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256092.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256116.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000256146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256249.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256271.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000256458.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000256482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256576.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000256705.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256789.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000256862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000256894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000256944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000256967.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000256973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000256988.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257135.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000257139.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257167.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257258.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257272.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257337.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257337.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000257366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000257366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257391.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257475.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257499.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257507.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000257527.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257621.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257681.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000257718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257732.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000257742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000257809.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257809.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000257809.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257815.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000257894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257906.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000257913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000257999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258001.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000258017.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000258057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000258057.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000258096.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000258096.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000258101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258168.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258249.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258260.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000258279.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000258279.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000258285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258302.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000258323.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258343.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000258399.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258410.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000258413.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000258414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258450.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000258457.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000258471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258521.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000258525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258535.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258558.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000258561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258623.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258658.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000258661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000258663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258670.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000258682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000258701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000258704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258733.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258733.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000258748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258754.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258813.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258813.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000258815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258819.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000258825.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000258831.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258837.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000258843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000258922.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000258922.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000258949.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000258976.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000258982.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259031.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000259039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000259084.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259088.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259088.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000259093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000259146.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259146.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000259153.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259212.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000259218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259277.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259306.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259322.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259336.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000259343.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000259345.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000259349.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259376.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000259377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259416.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259444.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259456.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259462.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000259475.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000259483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259488.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259514.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000259523.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000259527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000259540.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000259540.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000259543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259594.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259606.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259635.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000259640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259656.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000259668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259727.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000259736.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259758.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000259762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259771.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000259774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259774.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259804.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259806.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259820.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259820.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259843.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000259881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000259921.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000259942.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000259972.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260005.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000260006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000260008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000260051.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000260141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000260145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260156.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260167.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000260173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260233.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260269.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000260277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260279.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000260288.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260296.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260316.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260360.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260366.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000260367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000260369.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260381.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260388.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260394.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260394.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000260396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260398.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260417.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000260418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000260447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260455.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260466.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000260467.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000260470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260475.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260515.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000260519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260526.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260552.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260572.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260572.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000260579.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000260579.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260597.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260608.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260619.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000260625.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000260630.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260651.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000260651.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260657.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000260660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260735.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000260742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260773.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260777.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000260790.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000260793.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260804.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260804.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260804.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000260805.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260830.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000260833.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000260833.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000260838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260884.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260918.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260924.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260927.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260929.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260931.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260936.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260942.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000260947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000260954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000260973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000260973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260977.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000260992.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000261000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000261008.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261008.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000261024.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261024.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000261026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000261051.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261069.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261069.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261079.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261117.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000261123.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000261124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261124.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261159.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261173.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000261183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000261186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261195.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000261212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261216.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000261216.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000261220.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261235.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000261242.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000261253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000261286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261318.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261324.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000261341.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261342.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000261372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261372.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000261373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000261399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000261404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000261441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261469.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261469.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000261471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000261478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261488.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261512.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000261526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000261534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261597.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000261600.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261616.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000261633.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000261644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261662.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000261662.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000261663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261663.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000261673.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000261690.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000261693.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000261712.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000261730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261731.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261731.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000261737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000261737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261737.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000261757.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000261766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261824.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000261839.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000261864.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000261872.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000261886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000261916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000261971.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000261978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000261978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000261978.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000262098.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000262119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262147.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262152.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000262172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262185.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262223.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262228.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000262292.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262313.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000262339.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000262362.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262362.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000262477.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000262580.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000262580.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000262678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000262678.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000262678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262686.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262745.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000262766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262823.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000262837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000262837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262873.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000262877.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262879.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000262966.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000262973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000263004.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263050.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000263080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000263164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000263257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000263317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000263345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000263393.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263470.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000263624.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000263624.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000263627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000263657.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000263718.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000263718.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000263753.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000263766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263786.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000263874.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000263874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000263895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000263906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000263916.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000263916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000263923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000263975.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000264007.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264043.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000264107.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000264207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264270.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000264301.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000264304.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000264339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000264365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264365.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000264433.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000264456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000264469.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000264491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264514.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000264527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000264546.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000264548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264569.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000264575.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000264575.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000264577.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000264608.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000264635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000264647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000264745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000264808.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000264885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000264895.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000264932.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000264968.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000264968.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000265010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000265055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000265091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000265094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000265142.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000265148.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000265204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265222.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000265242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000265394.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265451.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000265451.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000265474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000265490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000265511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265656.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000265692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265728.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000265737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000265749.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000265750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265778.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000265791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000265799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000265845.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000265908.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000265912.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000265943.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266040.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266079.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000266088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000266088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266126.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266149.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000266278.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000266289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000266340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266402.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266466.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266541.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000266601.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266644.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266717.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000266744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266805.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000266821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000266844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266897.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266903.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266903.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000266904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266918.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000266922.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000266922.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000266926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266933.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000266933.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000266934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266942.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000266950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266975.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000266978.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000266983.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000266993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000266994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000266994.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267003.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000267006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267011.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267058.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267080.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000267100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267104.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267107.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000267169.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000267201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267221.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000267230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000267248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267251.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267259.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267268.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267272.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267273.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267280.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000267284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267325.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267345.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267345.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267348.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267348.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267405.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000267414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267421.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267421.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267491.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000267519.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267519.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000267543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267546.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267546.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267551.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267551.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267565.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267565.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267586.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267588.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267637.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267651.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267651.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000267659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267729.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267730.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000267730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267745.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000267745.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000267750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267759.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000267764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267765.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000267776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000267778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000267904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000267904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000267934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000267940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268047.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268047.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000268049.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268049.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000268061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268087.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000268157.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000268186.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000268201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000268307.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000268340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000268362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268364.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000268366.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000268388.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000268518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268543.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000268544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268549.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000268549.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000268564.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000268568.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268605.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000268613.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268670.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000268670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000268670.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268686.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268802.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268812.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000268836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000268947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000268981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269019.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000269044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269044.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269054.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269054.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000269399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269425.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269427.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269444.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000269463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269486.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000269487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269560.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000269609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269656.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269688.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000269694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269814.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269815.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000269836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000269843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269887.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269892.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000269898.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000269901.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000269908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269910.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000269911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269923.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269940.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000269949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269951.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000269958.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000269961.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000269979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000269997.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270009.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000270009.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000270010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000270012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270040.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270041.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270041.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000270048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270048.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000270049.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270049.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000270052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270060.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270062.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000270068.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000270074.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270095.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000270100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270103.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270120.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270141.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000270143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000270145.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000270157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000270157.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000270165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000270170.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000270171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270171.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000270174.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000270178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270195.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000270237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270246.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270346.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000270361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000270581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270599.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270604.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270704.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000270742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000270866.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000270883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000270933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000270964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271167.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000271172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271228.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271314.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000271327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271359.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271382.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271382.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000271387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271387.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000271398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271401.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000271401.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000271417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271551.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271553.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000271555.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000271590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271717.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271727.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271734.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000271738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271738.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271738.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000271751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271780.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271782.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271830.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271830.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271849.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000271857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271869.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000271882.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000271889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271943.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000271963.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271971.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271978.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000271983.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000271997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000271998.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272023.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272023.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000272023.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000272033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272033.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272043.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272070.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272076.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272097.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272102.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272103.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272108.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272109.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000272109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272128.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272141.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272156.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000272161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272181.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000272192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000272205.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272250.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000272254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272273.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272275.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272346.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272361.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272371.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272371.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272382.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000272382.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000272384.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000272386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272386.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272462.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272462.2 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000272465.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000272482.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272489.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272520.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000272520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272523.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000272524.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272524.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272529.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272558.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272567.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272588.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272610.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272631.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000272660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272663.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272689.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272690.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272702.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272717.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272734.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272761.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272764.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272764.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272784.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000272791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272795.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000272798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272800.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000272812.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272829.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000272836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272849.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272858.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000272859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272859.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000272862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272870.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Tanespimycin |
ENSG00000272871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272894.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000272912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000272927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272954.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000272984.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000272993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273000.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273008.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000273009.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273011.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000273017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273032.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Tanespimycin |
ENSG00000273033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273035.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000273058.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273075.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273107.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000273113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273113.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273113.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000273137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tanespimycin |
ENSG00000273137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000273153.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273165.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tanespimycin |
ENSG00000273175.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000273176.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tanespimycin |
ENSG00000273179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000273193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273203.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000273216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000273319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273321.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273321.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tanespimycin |
ENSG00000273329.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273329.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273335.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000273343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273343.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273352.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000273352.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000273353.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Tanespimycin |
ENSG00000273355.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000273372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273375.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tanespimycin |
ENSG00000273399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273406.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
ENSG00000273416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tanespimycin |
ENSG00000273437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tanespimycin |
ENSG00000273448.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Tanespimycin |
ENSG00000273456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273474.1 |
Predicted lncRNA |
Sarcoma |
|
| Tanespimycin |
ENSG00000273476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tanespimycin |
ENSG00000273493.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tanespimycin |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-1226-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-146a-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-181d |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-193a-3p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-219a-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-23b-3p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-24-3p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-27b-3p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-30a-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-483-3p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-575 |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-623 |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-770-5p |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
hsa-miR-892b |
predicted miRNA |
NCI60 |
|
| Tanespimycin |
miR-134 |
Curated miRNA |
breast cancer |
|
